FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On November 18, 2003
Table of Contents
Docket # Title
1995N-0304 Ephedrine Alkaloids: Reports of Adverse Events; Availability
1998F-0522 Formaldehyde Treated oilseed meal and fats for dairy & beef
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
1998V-0657 Laser Lighting Effects
1999F-4372 National Fisheries Institute and the Louisiana Dep of Agricu
1999F-5321 Food Safety & Inspection service safe use of ionizing radiai
1999F-5322 Ionizing Radiation for the Treatment of Food
1999F-5522 Ionizing radiation /control of Food-borne pathogens safe use
2001F-0047 Foodborne pathogens in raw-frozen-cooked-partially cooked
2002N-0276 Bioterrorism Preparedness; Registration of Food Facilities
2002N-0278 Bioterrorism; Prior Notice of Imported Food Shipments
2002N-0471 Cox-2 Inhibitors: Vioxx and Celebrex
2002P-0163 Expedite Over-the-Counter Approval for Desloratidine
2002P-0431 Delcobese Tablets and Capsules
2002V-0488 Laser Light Show
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
2003N-0324 Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in Sections 510.515 and/or 558.15; Drugs Efficacy Study Implementation; Notice of Opportunity for Hearing
2003N-0468 Medical Devices; Effective Date of Requirement for Premarket
2003P-0107 Synthroid (levothyroxine sodium) Tablets (NDA 21-402)
2003P-0113 Levoxyl (levothyroxine sodium) tablets (NDA #21-301)
2003P-0210 Withdraw decision granting petitions 03P-0107 and 03P-0113
2003P-0270 Prohibit False and Misleading Labeling
2003P-0274 In re Tier 1 initial Approval Program
2003P-0300 Cataflam (diclofenac potassium) Tablets 25 mg (NDA 20-142 voluntarily withdrawn or wtihheld from sale for safety or effectiveness reasons
2003V-0316 Laser Light Show
1995N-0304 Ephedrine Alkaloids: Reports of Adverse Events; Availability
C 4048 William (Bill) Popin Vol #: 374
1998F-0522 Formaldehyde Treated oilseed meal and fats for dairy & beef
FONS 1 HFV-220 Vol #: 1
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
C 7273 Kathleen Garron Vol #: 303
C 7274 Monica Lebelt Vol #: 303
1998V-0657 Laser Lighting Effects
VRA 3 HFZ-300 to Viejas Casino and Turf Club Vol #: 1
1999F-4372 National Fisheries Institute and the Louisiana Dep of Agricu
C 79
Tab 1, 2, 3, 4, 5, 6, 7
Public Citizen and The Center for Food Safety Vol #: 8
1999F-5321 Food Safety & Inspection service safe use of ionizing radiai
C 77
Tab 1, 2, 3, 4, 5, 6. 7
Public Citizen and The Center for Food Safety Vol #: 8
1999F-5322 Ionizing Radiation for the Treatment of Food
C 76
Tab 1, 2, 3, 4, 5, 6. 7
Public Citizen and The Center for Food Safety Vol #: 6
1999F-5522 Ionizing radiation /control of Food-borne pathogens safe use
C 80
Tab 1, 2, 3, 4, 5, 6. 7
Public Citizen and The Center for Food Safety Vol #: 6
2001F-0047 Foodborne pathogens in raw-frozen-cooked-partially cooked
C 75
Tab 1, 2, 3, 4, 5, 6. 7
Public Citizen and The Center for Food Safety Vol #: 8
2002N-0276 Bioterrorism Preparedness; Registration of Food Facilities
C 166 Asociacion de Exportadores de Chile, AG (ASOEX) Vol #: 15
2002N-0278 Bioterrorism; Prior Notice of Imported Food Shipments
C 235 Asociacion de Exportadores de Chile, AG (ASOEX) Vol #: 17
2002N-0471 Cox-2 Inhibitors: Vioxx and Celebrex
LET 2 HF-22 to Honorable Sterling Johnson, Jr. Vol #: 1
2002P-0163 Expedite Over-the-Counter Approval for Desloratidine
C 6 Honorable Sanford D. Bishop, Jr. Vol #: 1
2002P-0431 Delcobese Tablets and Capsules
LET 3 HFD-007 to Sonnenschein Nath & Rosenthal Vol #: 1
2002V-0488 Laser Light Show
VRA 1 HFZ-300 to Robert Urschel Vol #: 1
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
C 13 / ANS HFS-306 to Ed Moon Vol #: 3
2003N-0324 Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in Sections 510.515 and/or 558.15; Drugs Efficacy Study Implementation; Notice of Opportunity for Hearing
CR 1 Buchanan Ingersoll Vol #: 1
CR 2 Buchanan Ingersoll Vol #: 1
2003N-0468 Medical Devices; Effective Date of Requirement for Premarket
N 1 Number not used Vol #: 1
NPR 1 FDA Vol #: 1
2003P-0107 Synthroid (levothyroxine sodium) Tablets (NDA 21-402)
PDN 1 HF-22 to Hogan & Hartson, LLP Vol #: 1
2003P-0113 Levoxyl (levothyroxine sodium) tablets (NDA #21-301)
PDN 1 HF-22 to Hogan & Hartson, LLP Vol #: 1
2003P-0210 Withdraw decision granting petitions 03P-0107 and 03P-0113
PDN 1 HF-22 to Hogan & Hartson, LLP Vol #: 1
2003P-0270 Prohibit False and Misleading Labeling
C 41 Nora M. Cuddy Vol #: 6
2003P-0274 In re Tier 1 initial Approval Program
C 9 Abigail Alliance and the Washington Legal Foundation Vol #: 1
2003P-0300 Cataflam (diclofenac potassium) Tablets 25 mg (NDA 20-142 voluntarily withdrawn or wtihheld from sale for safety or effectiveness reasons
N 1 FDA Vol #: 1
2003V-0316 Laser Light Show
VRA 1 HFZ-300 to Imagery Laser Vol #: 1

Page Created 11/19/2003 dp
Page updated 12/10/2003 jb

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management